About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gabra5tm1Twr
targeted mutation 1, Thomas W Rosahl
MGI:3623342
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gabra5tm1Twr/Gabra5tm1Twr involves: 129S7/SvEvBrd MGI:3624522
hm2
Gabra5tm1Twr/Gabra5tm1Twr involves: 129S7/SvEvBrd * C57BL/6 MGI:3624523


Genotype
MGI:3624522
hm1
Allelic
Composition
Gabra5tm1Twr/Gabra5tm1Twr
Genetic
Background
involves: 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gabra5tm1Twr mutation (0 available); any Gabra5 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• etomidate impairs the acquisition of contextual fear in wild-type mice but not in Gabra5-deficient animals
• etomidate does not affect memory performance in mutant mice, but impairs spatial learning by wild-type mice in a Morris water maze

nervous system
• in Gabra5 knockout mice, etomidate does not increase the holding current as it does in wild-type neurons
• etomidate does not attenuate LTP in pyramidal neurons in brain slices of mutants; LTP is sustained after 60 minutes, while in control slices it decreases after an intial increase




Genotype
MGI:3624523
hm2
Allelic
Composition
Gabra5tm1Twr/Gabra5tm1Twr
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gabra5tm1Twr mutation (0 available); any Gabra5 mutation (30 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• Gabra5-deficient mice show improved memory compared to controls in a Morris water maze 'matching-to-place' test

hearing/vestibular/ear
• at 6-10 weeks, homozygotes display minimal cochlear histopathology, with little hair cell loss outside of the extreme cochlear base
• at >24 weeks, homozygotes exhibit basal-turn histopathology
• at ~24 weeks, homozygotes display a nearly complete loss of IHCs throughout the basal 15% of the cochlear spiral, i.e. from 40 to 90 kHz according to the mouse cochlear frequency map
• however, at 6 weeks, efferent innervation density in the 16 kHz region is still normal, consistent with normal magnitudes of shock-evoked efferent effects observed at this age
• at 24 weeks, degeneration of OHC efferent terminals is observed, as shown by reduced VAT-positive terminals
• no changes in efferent terminal development are noted up to 3 weeks of age
• importantly, no significant loss of afferent terminals is noted at 24 weeks
• at ~24 weeks, homozygotes display a nearly complete loss of OHCs throughout the basal 15% of the cochlear spiral, i.e. from 40 to 90 kHz according to the mouse cochlear frequency map
• at 6-10 weeks, homozygotes show loss of type IV fibrocytes in the spiral ligament of the basal turn
• at >24 weeks, loss of type IV fibrocytes is extended farther apically than at 6 weeks of age
• at 6 weeks, amplitudes of ABR suprathreshold responses (wave 1) of homozygotes are reduced by 25-50% relative to wild-type mice, even at the highest test stimulus levels
• at 6 weeks, homozygotes display cochlear dysfunction, as shown by significant ABR threshold shifts increasing from <5 to 20-30 dB with increasing tone frequency
• however, at 6 weeks, homozygotes show no significant differences in cochlear vulnerability to acoustic trauma (measured via ABRs and DPOAEs at 12 hrs after a 2-hr exposure to a 8-16 kHz noise band at 89 dB SPL) or in recovery from acoustic trauma at 7 days after overexposure relative to age-matched wild-type control mice
• at 24 weeks, cochlear dysfunction is exacerbated, as mean ABR threshold shifts are shown to peak at 45 dB for test frequencies in the middle of the cochlea (16 kHz)
• at 24 weeks, ABR threshold shifts are significantly larger than the observed DPOAE shifts
• no sexual dimorphism is observed at 24 weeks with respect to ABR threshold shifts
• at 6 weeks, homozygotes display increasing DPOAE threshold shifts from low to high frequencies
• at 24 weeks, ABR threshold shifts are significantly larger than the observed DPOAE shifts
• however, at 6 weeks, ABR shifts at 16 kHz (middle cochlear region) are similar in magnitude to the observed DPOAE shifts, suggesting that the ongoing degeneration is a type of neuropathy
• in addition, at 6 weeks, OHC efferent function remains unaffected, as assessed by measuring DPOAE suppression caused by efferent-bundle shocks

nervous system
• at ~24 weeks, homozygotes display a nearly complete loss of IHCs throughout the basal 15% of the cochlear spiral, i.e. from 40 to 90 kHz according to the mouse cochlear frequency map
• however, at 6 weeks, efferent innervation density in the 16 kHz region is still normal, consistent with normal magnitudes of shock-evoked efferent effects observed at this age
• at 24 weeks, degeneration of OHC efferent terminals is observed, as shown by reduced VAT-positive terminals
• no changes in efferent terminal development are noted up to 3 weeks of age
• importantly, no significant loss of afferent terminals is noted at 24 weeks
• at ~24 weeks, homozygotes display a nearly complete loss of OHCs throughout the basal 15% of the cochlear spiral, i.e. from 40 to 90 kHz according to the mouse cochlear frequency map
• at >24 weeks, homozygotes show partial loss of spiral ganglion cells but only in cochlear regions in which IHCs are degenerated
• in mutants the mean peak amplitude of spontaneous IPSCs are significantly smaller than in wild-type mice
• fewer cells in mutant mice show a fast inactivating component to the IPSC compared to wild-type

skeleton
• at 6-10 weeks, homozygotes show loss of type IV fibrocytes in the spiral ligament of the basal turn
• at >24 weeks, loss of type IV fibrocytes is extended farther apically than at 6 weeks of age





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory